Home Machinery & Equipment Industrial Equipment Doxorubicin Market

Doxorubicin Market Size, Share & Trends Analysis Report By Formulation (Lyophilized Powder, Doxorubicin Injection), By Application (Ovarian Cancer, Breast Cancer, Kaposi Sarcoma, Leukemia, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Doxorubicin Market, By Formulation 2022-2034 (USD MILLION/ Units)
    1. Lyophilized Powder
    2. Doxorubicin Injection
  2. Doxorubicin Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Ovarian Cancer
    2. Breast Cancer
    3. Kaposi Sarcoma
    4. Leukemia
    5. Others
  3. Doxorubicin Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Online Pharmacy
  4. Regional Doxorubicin Market
    1. North America
      1. North America Doxorubicin Market By Formulation 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Doxorubicin Injection
      2. North America Doxorubicin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Ovarian Cancer
        2. Breast Cancer
        3. Kaposi Sarcoma
        4. Leukemia
        5. Others
      3. North America Doxorubicin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. U.S.
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      5. Canada
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
    2. Europe
      1. Europe Doxorubicin Market By Formulation 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Doxorubicin Injection
      2. Europe Doxorubicin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Ovarian Cancer
        2. Breast Cancer
        3. Kaposi Sarcoma
        4. Leukemia
        5. Others
      3. Europe Doxorubicin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. U.K.
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      5. Germany
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      6. France
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      7. Spain
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      8. Italy
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      9. Russia
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      10. Nordic
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      11. Benelux
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      12. Rest of Europe
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
    3. APAC
      1. APAC Doxorubicin Market By Formulation 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Doxorubicin Injection
      2. APAC Doxorubicin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Ovarian Cancer
        2. Breast Cancer
        3. Kaposi Sarcoma
        4. Leukemia
        5. Others
      3. APAC Doxorubicin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. China
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      5. Korea
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      6. Japan
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      7. India
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      8. Australia
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      9. Taiwan
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      10. South East Asia
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      11. Rest of Asia-Pacific
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
    4. Middle East and Africa
      1. Middle East and Africa Doxorubicin Market By Formulation 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Doxorubicin Injection
      2. Middle East and Africa Doxorubicin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Ovarian Cancer
        2. Breast Cancer
        3. Kaposi Sarcoma
        4. Leukemia
        5. Others
      3. Middle East and Africa Doxorubicin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. UAE
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      5. Turkey
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      6. Saudi Arabia
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      7. South Africa
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      8. Egypt
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      9. Nigeria
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      10. Rest of MEA
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
    5. LATAM
      1. LATAM Doxorubicin Market By Formulation 2022-2034 (USD MILLION/ Units)
        1. Lyophilized Powder
        2. Doxorubicin Injection
      2. LATAM Doxorubicin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Ovarian Cancer
        2. Breast Cancer
        3. Kaposi Sarcoma
        4. Leukemia
        5. Others
      3. LATAM Doxorubicin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. Brazil
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      5. Mexico
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      6. Argentina
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      7. Chile
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      8. Colombia
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
      9. Rest of LATAM
        1. Lyophilized Powder
        2. Doxorubicin Injection
        3. Ovarian Cancer
        4. Breast Cancer
        5. Kaposi Sarcoma
        6. Leukemia
        7. Others
        8. Hospital Pharmacy
        9. Retail Pharmacy
        10. Online Pharmacy
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.